Fieldpoint Private Securities’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3K Sell
50
-70
-58% -$4.06K ﹤0.01% 1013
2022
Q1
$9K Buy
120
+70
+140% +$4.78K ﹤0.01% 1093
2021
Q4
$4K Hold
50
﹤0.01% 1297
2021
Q3
$2K Hold
50
﹤0.01% 1433
2021
Q2
$2K Sell
50
-1,114
-96% -$46.2K ﹤0.01% 1360
2021
Q1
$48K Buy
1,164
+1,114
+2,228% +$41.5K 0.01% 573
2020
Q4
$1K Buy
+50
New +$1.29K ﹤0.01% 1365

Other funds holding ACLS

Fieldpoint Private Securities's ACLS Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Axcelis (ACLS) stake by 58% in Q2 2022, selling an estimated $4.06K and leaving 50 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

Fieldpoint Private Securities first reported a position in ACLS in Q4 2020 and has held it in 7 quarters since. The position peaked at $48K in Q1 2021. 276 funds tracked by Wall St. Rank hold ACLS as of Q2 2022.

  • Fieldpoint Private Securities held 50 shares of Axcelis worth $3K as of Q2 2022.
  • Fieldpoint Private Securities sold 70 Axcelis shares in Q2 2022, an estimated $4.06K.
  • Axcelis made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1013 holding.
  • Fieldpoint Private Securities first reported a position in Axcelis in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Axcelis position peaked at $48K in Q1 2021.
  • 276 funds tracked by Wall St. Rank held Axcelis as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.